Close

Ackman's Pershing Square Updates on Valeant Pharma (VRX) Options Position

June 13, 2016 6:31 AM EDT Send to a Friend
Bill Ackman's Pershing Square filed an amended 13D on Valeant Pharma (NYSE: VRX) with the U.S. SEC on Friday ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login